IP Library Granted Patent US 9,579,252
Granted Patent B2
US 9,579,252 · App. 14/716,269 · Granted Feb 28, 2017

Sealable secondary packaging for pharmaceutical product blister pack

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,579,252
App. No.
14/716,269
Granted
Feb 28, 2017
Kind
B2
Abstract

A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g., now being in a form that should reduce the potential for gaining access to any remaining pharmaceutical product still enclosed within the pharmaceutical product receiver).

Claims (50)

1. A pharmaceutical product supply, comprising:

a container collectively defined by a first panel and a second panel, wherein said first panel comprises first and second sides that are disposed opposite of one another, wherein said first panel lacks any openable access, wherein said second panel comprises first and second sides that are disposed opposite of one another, wherein said second panel incorporates a pharmaceutical product receiver, wherein said pharmaceutical product receiver comprises a plurality of receptacles, and wherein each receptacle of said plurality of receptacles comprises an opening;

pharmaceutical product within at least one of said plurality of receptacles of said pharmaceutical product receiver;

each said receptacle of said plurality of receptacles that includes said pharmaceutical product having a corresponding covering over its corresponding said opening, wherein each said corresponding covering encloses said pharmaceutical product in its corresponding said receptacle, and wherein each said corresponding covering is accessible from said first side of said second panel;

a first adhesive;

a first release liner;

a first configuration comprising said first release liner being disposed over said first adhesive, wherein with said pharmaceutical product supply being in said first configuration: 1) said first panel is movable relative to said second panel between an open position for said pharmaceutical product supply and a closed position for said pharmaceutical product supply; 2) said first panel is positioned over said first side of said second panel when said pharmaceutical product supply is in said closed position; and 3) said first release liner is positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

a second configuration comprising said first release liner being removed to expose said first adhesive, wherein with said pharmaceutical product supply being in said second configuration: 1) said first panel is movable relative to said second panel to said closed position for said pharmaceutical product supply; 2) said first side of said first panel is positioned in interfacing relation with said first side of said second panel when said pharmaceutical product supply is in said closed position; 3) said first side of said first panel is bonded to said first side of said second panel using said first adhesive when said pharmaceutical product supply is in said closed position; and 4) said second side of said first panel and said second side of said second panel define exterior surfaces of said container.

2. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver is separately mounted to said second panel.

3. The pharmaceutical product supply of claim 2 , wherein said first adhesive is disposed on said first side of said second panel and is positioned about said pharmaceutical product receiver.

4. The pharmaceutical product supply of claim 1 , wherein said second panel comprises an internal storage area and an opening in said first side of said second panel that leads to said internal storage area, and wherein said pharmaceutical product receiver is disposed within said internal storage area.

5. The pharmaceutical product supply of claim 4 , further comprising a plurality of pharmaceutical product receivers within said internal storage area.

6. The pharmaceutical product supply of claim 4 , wherein said first adhesive is disposed on said first side of said second panel so as to be on a perimeter of said opening.

7. The pharmaceutical product supply of claim 6 , further comprising:

a second adhesive on said first side of said first panel; and

a second release liner;

wherein said first configuration further comprises said second release liner being disposed over said second adhesive such that said second release liner is also positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

wherein said second configuration further comprises said second release liner being removed to expose said second adhesive such that said first side of said first panel is bonded to said first side of said second panel using both said first adhesive and said second adhesive when said pharmaceutical product supply is in said closed position.

8. The pharmaceutical product supply of claim 1 , wherein said first adhesive is disposed on said first side of said second panel.

9. The pharmaceutical product supply of claim 8 , further comprising:

a second adhesive on said first side of said first panel; and

a second release liner;

wherein said first configuration further comprises said second release liner being disposed over said second adhesive such that said second release liner is also positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

wherein said second configuration further comprises said second release liner being removed to expose said second adhesive such that said first side of said first panel is bonded to said first side of said second panel using both said first adhesive and said second adhesive when said pharmaceutical product supply is in said closed position.

10. The pharmaceutical product supply of claim 1 , wherein said first adhesive is disposed on said first side of said first panel.

11. The pharmaceutical product supply of claim 1 , further comprising:

a fold line between said first panel and said second panel, wherein with said pharmaceutical product supply being in said first configuration, said first panel is movable relative to said second panel about said fold line between said open position for said pharmaceutical product supply and said closed position for said pharmaceutical product supply.

12. The pharmaceutical product supply of claim 1 , wherein said container comprises secondary packaging and said pharmaceutical product receiver comprises primary packaging.

13. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product in each said receptacle comprises a single dose.

14. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver comprises a blister card.

15. The pharmaceutical product supply of claim 1 , wherein said pharmaceutical product receiver defines said second panel.

16. The pharmaceutical product supply of claim 1 , further comprising a sheet that extends over each said opening of said pharmaceutical product receiver such that each said corresponding covering is defined by a different portion of said sheet.

17. A pharmaceutical product supply, comprising:

a container collectively defined by a first panel and a second panel, wherein said first panel comprises first and second sides that are disposed opposite of one another, wherein said first panel lacks any openable access, wherein said second panel comprises first and second sides that are disposed opposite of one another, wherein said second panel incorporates a pharmaceutical product receiver, and wherein said pharmaceutical product receiver comprises a plurality of receptacles;

pharmaceutical product enclosed within each of said plurality of receptacles of said pharmaceutical product receiver and separately removable from each receptacle of said plurality of receptacles through a common first side of said pharmaceutical product receiver;

a first adhesive;

a first release liner;

a first configuration comprising said first release liner being disposed over said first adhesive, wherein with said pharmaceutical product supply being in said first configuration: 1) said first panel is movable relative to said second panel between an open position for said pharmaceutical product supply and a closed position for said pharmaceutical product supply; 2) said first panel is positioned over said first side of said second panel when said pharmaceutical product supply is in said closed position; and 3) said first release liner is positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

a second configuration comprising said first release liner being removed to expose said first adhesive, wherein with said pharmaceutical product supply being in said second configuration: 1) said first panel is movable relative to said second panel to said closed position for said pharmaceutical product supply; 2) said first side of said first panel is positioned in interfacing relation with said first side of said second panel when said pharmaceutical product supply is in said closed position; 3) said first side of said first panel is bonded to said first side of said second panel using said first adhesive when said pharmaceutical product supply is in said closed position; and 4) said second side of said first panel and said second side of said second panel define exterior surfaces of said container.

18. The pharmaceutical product supply of claim 17 , wherein said pharmaceutical product receiver defines said second panel.

19. The pharmaceutical product supply of claim 17 , wherein said second panel comprises an internal storage area and an opening in said first side of said second panel that leads to said internal storage area, and wherein said pharmaceutical product receiver is disposed within said internal storage area, wherein said first adhesive is disposed on said first side of said second panel so as to be on a perimeter of said opening, said pharmaceutical product supply further comprising:

a second adhesive on said first side of said first panel; and

a second release liner;

wherein said first configuration further comprises said second release liner being disposed over said second adhesive such that said second release liner is also positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

wherein said second configuration further comprises said second release liner being removed to expose said second adhesive such that said first side of said first panel is bonded to said first side of said second panel using both said first adhesive and said second adhesive when said pharmaceutical product supply is in said closed position.

20. The pharmaceutical product supply of claim 17 , wherein said first adhesive is disposed on said first side of said second panel, said pharmaceutical product supply further comprising:

a second adhesive on said first side of said first panel; and

a second release liner;

wherein said first configuration further comprises said second release liner being disposed over said second adhesive such that said second release liner is also positioned between said first panel and said first side of said second panel when said pharmaceutical product supply is in said closed position; and

wherein said second configuration further comprises said second release liner being removed to expose said second adhesive such that said first side of said first panel is bonded to said first side of said second panel using both said first adhesive and said second adhesive when said pharmaceutical product supply is in said closed position.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 31, 2025
From: SPECGX LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 072313/0063 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 039237, FRAME 0147 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0902 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2017
From: MALLINCKRODT LLC
To: SPECGX LLC
Reel/Frame 044891/0376 →